摘要
目的:观察静脉注射胺碘酮或普罗帕酮治疗阵发性室上性心动过速(PSVT)的疗效及副作用。方法:静脉注射胺碘酮治疗44例PSVT,并与普罗帕酮静脉注射治疗46例PSVT对比观察。结果:胺碘酮组和普罗帕酮组总终止率分别为82%和85%,无显著差异(P>0.05);复律时间:胺碘酮组的20±5min明显慢于普罗帕酮组的8.5±2.5min(P<0.05);副作用发生率二者无显著差异性,但普罗帕酮组的副作用较重。结论:胺碘酮治疗PSVT疗效确切、安全,可作为治疗PSVT的一线药物之一。
Objective： To observe the effects and side effects of intravenous Amiodarone and Propafenone in treating paroxysmal supraventricular tachycardia （PSVT）. Methods： 44 patients of PSVT were treated with intravenous Amiodarone and the other 46 patients of PSVT were treated with intravenous Propafenone. Results： It has been shown that the termination rate of PSVT was 82% in amiodarone group and 85% in Propafenone group respectively （P 〉 0.05）. The time from Amiodarone injection to termination of PSVT was later Prepafenone-group （20±5 s and 8.5±2.5 s, respectively（P 〈 0.05）. But there is no difference between the two groups in the incidence of side effects. Conclusions： It is efficacy and safety of intravenous Amiodarene in treating PSVT, and it can be first given intravenously for termination of PSVT.
出处
《岭南急诊医学杂志》
2006年第3期167-168,共2页
Lingnan Journal of Emergency Medicine
关键词
胺碘酮
普罗帕酮
阵发性室上性心动过速
Amiodarone
Prepafenone
paroxysmal supraventricular tachycardia
